Nifty
Sensex
:
:
14504.80
48544.06
194.00 (1.36%)
660.68 (1.38%)

Pharmaceuticals & Drugs - Global

Rating :
40/99

BSE: 506690 | NSE: UNICHEMLAB

311.45
12-Apr-2021
  • Open
  • High
  • Low
  • Previous Close
  •  324.00
  •  339.50
  •  308.85
  •  324.25
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  275743
  •  905.20
  •  360.60
  •  121.10

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 2,197.36
  • 125.24
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 2,147.59
  • 1.28%
  • 0.87

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 50.93%
  • 2.80%
  • 30.76%
  • FII
  • DII
  • Others
  • 1.55%
  • 8.59%
  • 5.37%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 3.92
  • -1.90
  • -4.27

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 15.65
  • 0.63
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.95
  • 1.68
  • 1.00

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 19.83
  • 24.78
  • 31.80

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 20
Dec 19
Var%
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Net Sales
326.28
274.83
18.72%
317.51
268.14
18.41%
317.27
273.20
16.13%
320.23
374.90
-14.58%
Expenses
296.17
291.99
1.43%
287.65
294.94
-2.47%
305.19
293.42
4.01%
306.87
349.56
-12.21%
EBITDA
30.12
-17.16
-
29.86
-26.81
-
12.08
-20.22
-
13.36
25.34
-47.28%
EBIDTM
9.23%
-6.24%
9.40%
-10.00%
3.81%
-7.40%
4.17%
6.76%
Other Income
15.61
25.10
-37.81%
10.04
28.13
-64.31%
16.71
26.26
-36.37%
11.82
20.71
-42.93%
Interest
1.27
2.32
-45.26%
0.79
1.86
-57.53%
1.25
1.28
-2.34%
2.40
4.22
-43.13%
Depreciation
20.82
19.47
6.93%
21.13
20.98
0.71%
20.54
18.25
12.55%
22.96
19.03
20.65%
PBT
23.64
-13.85
-
17.98
-21.51
-
7.00
-13.49
-
-0.17
22.81
-
Tax
-0.07
1.20
-
9.25
0.68
1,260.29%
4.61
-7.53
-
17.63
-9.01
-
PAT
23.71
-15.05
-
8.74
-22.19
-
2.39
-5.96
-
-17.80
31.82
-
PATM
7.27%
-5.48%
2.75%
-8.27%
0.75%
-2.18%
-5.56%
8.49%
EPS
3.35
-2.07
-
1.24
-3.15
-
0.35
-0.88
-
-2.44
5.40
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
1,281.29
1,210.62
1,188.19
1,379.90
1,540.06
1,332.65
1,201.79
1,133.45
1,080.80
875.46
824.04
Net Sales Growth
7.57%
1.89%
-13.89%
-10.40%
15.56%
10.89%
6.03%
4.87%
23.46%
6.24%
 
Cost Of Goods Sold
419.44
308.19
364.19
274.97
188.77
386.97
378.57
332.84
343.06
278.55
237.98
Gross Profit
861.85
902.43
823.99
1,104.93
1,351.28
945.67
823.23
800.61
737.75
596.91
586.07
GP Margin
67.26%
74.54%
69.35%
80.07%
87.74%
70.96%
68.50%
70.63%
68.26%
68.18%
71.12%
Total Expenditure
1,195.88
1,261.44
1,269.21
1,358.21
1,357.62
1,168.77
1,100.79
955.75
910.06
759.42
674.08
Power & Fuel Cost
-
73.02
76.39
49.23
41.62
38.25
39.39
35.97
31.36
26.22
22.50
% Of Sales
-
6.03%
6.43%
3.57%
2.70%
2.87%
3.28%
3.17%
2.90%
2.99%
2.73%
Employee Cost
-
273.28
238.52
200.64
169.04
255.92
223.20
187.37
164.88
140.06
123.99
% Of Sales
-
22.57%
20.07%
14.54%
10.98%
19.20%
18.57%
16.53%
15.26%
16.00%
15.05%
Manufacturing Exp.
-
151.01
147.23
125.30
103.70
150.54
145.03
137.05
119.15
101.54
102.67
% Of Sales
-
12.47%
12.39%
9.08%
6.73%
11.30%
12.07%
12.09%
11.02%
11.60%
12.46%
General & Admin Exp.
-
228.99
229.37
594.53
744.66
167.66
153.29
127.77
104.73
88.54
79.74
% Of Sales
-
18.92%
19.30%
43.09%
48.35%
12.58%
12.76%
11.27%
9.69%
10.11%
9.68%
Selling & Distn. Exp.
-
223.02
197.24
108.38
107.77
166.84
157.12
134.03
135.93
116.00
106.52
% Of Sales
-
18.42%
16.60%
7.85%
7.00%
12.52%
13.07%
11.82%
12.58%
13.25%
12.93%
Miscellaneous Exp.
-
3.93
16.26
5.16
2.06
2.58
4.19
0.73
10.97
8.50
106.52
% Of Sales
-
0.32%
1.37%
0.37%
0.13%
0.19%
0.35%
0.06%
1.01%
0.97%
0.08%
EBITDA
85.42
-50.82
-81.02
21.69
182.44
163.88
101.00
177.70
170.74
116.04
149.96
EBITDA Margin
6.67%
-4.20%
-6.82%
1.57%
11.85%
12.30%
8.40%
15.68%
15.80%
13.25%
18.20%
Other Income
54.18
91.31
98.41
3,278.19
5.50
19.11
20.72
42.38
16.96
12.50
8.32
Interest
5.71
7.85
7.52
8.01
3.36
2.90
3.04
3.19
3.29
4.08
2.39
Depreciation
85.45
81.67
67.37
50.51
43.52
38.79
41.27
45.72
38.34
30.43
29.22
PBT
48.45
-49.02
-57.50
3,241.36
141.07
141.31
77.41
171.17
146.07
94.03
126.66
Tax
31.42
11.97
-33.64
696.23
32.58
29.30
2.13
43.00
32.85
22.77
31.68
Tax Rate
64.85%
-24.42%
58.50%
21.48%
23.09%
21.27%
2.75%
25.12%
22.49%
24.22%
25.01%
PAT
17.04
-61.00
-23.87
2,545.13
108.49
108.48
75.28
128.16
113.23
71.26
94.98
PAT before Minority Interest
17.04
-61.00
-23.87
2,545.13
108.49
108.48
75.28
128.16
113.23
71.26
94.98
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
1.33%
-5.04%
-2.01%
184.44%
7.04%
8.14%
6.26%
11.31%
10.48%
8.14%
11.53%
PAT Growth
249.74%
-
-
2,245.96%
0.01%
44.10%
-41.26%
13.19%
58.90%
-24.97%
 
EPS
2.42
-8.66
-3.39
361.52
15.41
15.41
10.69
18.20
16.08
10.12
13.49

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
2,531.35
2,619.91
2,680.08
1,063.62
954.33
867.52
816.61
727.07
660.58
617.70
Share Capital
14.08
14.08
14.07
18.18
18.17
18.15
18.13
18.09
18.06
18.05
Total Reserves
2,512.44
2,601.99
2,665.42
1,044.00
935.01
848.52
797.74
707.98
641.80
598.85
Non-Current Liabilities
43.72
10.10
46.46
64.49
76.02
74.21
97.72
94.31
92.67
87.44
Secured Loans
0.00
0.00
0.33
0.44
22.98
20.35
24.65
20.89
20.47
19.01
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
23.49
22.72
Long Term Provisions
23.51
14.60
10.76
25.33
12.58
8.88
7.64
9.19
10.24
7.90
Current Liabilities
566.73
502.92
463.51
392.62
275.09
211.76
230.32
251.12
233.30
176.15
Trade Payables
250.22
221.41
226.23
210.73
163.95
138.23
150.52
156.63
140.30
109.99
Other Current Liabilities
122.04
68.45
63.03
68.01
60.56
45.86
32.99
36.65
34.28
26.00
Short Term Borrowings
184.03
199.67
150.29
97.62
12.93
1.63
1.04
6.17
25.42
9.04
Short Term Provisions
10.44
13.39
23.97
16.25
37.65
26.05
45.78
51.67
33.30
31.13
Total Liabilities
3,141.80
3,132.93
3,190.05
1,520.73
1,305.44
1,153.49
1,144.65
1,072.50
986.55
881.29
Net Block
866.06
806.29
574.45
487.22
402.60
415.99
419.29
447.76
408.39
377.31
Gross Block
1,103.64
975.96
689.74
561.37
439.53
724.65
688.25
675.87
599.27
537.04
Accumulated Depreciation
237.59
169.67
115.29
74.15
36.92
308.66
268.96
228.11
190.87
159.73
Non Current Assets
1,455.33
1,093.64
853.59
772.27
673.34
589.07
563.97
594.06
547.20
456.50
Capital Work in Progress
330.47
92.39
238.15
249.98
237.13
122.64
90.54
132.20
112.76
62.87
Non Current Investment
134.38
129.20
9.20
9.51
5.54
5.83
5.72
5.72
0.03
0.03
Long Term Loans & Adv.
112.90
56.37
24.05
25.57
28.05
44.61
48.42
8.38
26.02
16.29
Other Non Current Assets
11.52
9.39
7.74
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
1,686.47
2,039.29
2,336.47
748.46
632.11
564.42
580.68
478.44
439.35
424.79
Current Investments
419.10
800.75
895.55
8.00
8.04
35.04
5.67
33.06
14.50
21.29
Inventories
396.54
338.66
272.86
281.71
230.57
207.68
203.49
143.05
157.96
150.26
Sundry Debtors
390.14
436.05
276.92
315.32
220.09
191.58
196.51
206.95
183.25
185.13
Cash & Bank
233.81
200.99
681.46
16.14
20.13
26.96
52.15
24.64
23.23
15.16
Other Current Assets
246.88
68.65
64.17
28.49
153.28
103.17
122.86
70.75
60.40
52.95
Short Term Loans & Adv.
183.04
194.18
145.51
98.80
122.77
82.25
105.67
61.73
53.14
47.14
Net Current Assets
1,119.74
1,536.37
1,872.95
355.84
357.02
352.66
350.36
227.32
206.05
248.65
Total Assets
3,141.80
3,132.93
3,190.06
1,520.73
1,305.45
1,153.49
1,144.65
1,072.50
986.55
881.29

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
19.82
-327.77
-112.34
68.19
111.91
78.10
86.73
171.23
124.08
68.59
PBT
-48.21
-57.44
3,241.14
141.25
137.68
77.41
171.17
146.07
94.03
126.66
Adjustment
18.79
6.80
-3,207.66
53.31
39.65
35.57
18.74
47.15
39.37
27.54
Changes in Working Capital
53.58
-264.94
-146.67
-98.65
-34.16
-16.49
-66.32
13.05
13.51
-54.81
Cash after chg. in Working capital
24.15
-315.57
-113.20
95.91
143.16
96.49
123.58
206.27
146.91
99.39
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-4.34
-12.20
0.86
-27.72
-31.25
-18.39
-36.85
-35.04
-22.83
-30.81
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-41.21
-286.01
1,648.33
-127.87
-85.33
-52.34
35.70
-118.45
-101.80
-47.60
Net Fixed Assets
-338.73
-139.02
-107.71
-135.60
154.89
-73.58
38.14
-92.98
-106.47
-67.03
Net Investments
374.24
-63.59
-889.36
17.40
42.09
-32.73
20.34
-34.14
-5.98
28.17
Others
-76.72
-83.40
2,645.40
-9.67
-282.31
53.97
-22.78
8.67
10.65
-8.74
Cash from Financing Activity
-62.30
-2.42
-881.13
59.23
-33.42
-50.95
-94.92
-51.38
-14.21
-29.46
Net Cash Inflow / Outflow
-83.69
-616.19
654.86
-0.46
-6.84
-25.19
27.51
1.41
8.07
-8.48
Opening Cash & Equivalents
197.05
666.07
11.21
11.67
26.96
52.15
24.64
23.23
15.16
23.64
Closing Cash & Equivalent
226.22
197.05
666.07
11.21
20.13
26.96
52.15
24.64
23.23
15.16

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
358.85
371.69
380.95
116.88
104.93
95.48
90.02
80.27
73.06
68.36
ROA
-1.94%
-0.75%
108.06%
7.68%
8.82%
6.55%
11.56%
11.00%
7.63%
11.31%
ROE
-2.37%
-0.90%
136.04%
10.77%
11.92%
8.95%
16.62%
16.34%
11.16%
16.11%
ROCE
-1.49%
-1.77%
162.77%
13.42%
14.97%
9.29%
21.84%
20.13%
14.03%
20.37%
Fixed Asset Turnover
1.16
1.43
2.21
3.08
2.32
1.71
1.67
1.71
1.55
1.66
Receivable days
124.55
109.51
78.30
63.41
55.72
58.55
64.53
65.42
76.34
77.46
Inventory Days
110.83
93.93
73.33
60.67
59.32
62.03
55.42
50.47
63.88
56.72
Payable days
74.71
73.41
94.97
104.25
52.00
52.61
62.52
65.77
65.64
63.82
Cash Conversion Cycle
160.67
130.03
56.65
19.82
63.05
67.97
57.43
50.11
74.58
70.36
Total Debt/Equity
0.07
0.08
0.06
0.09
0.04
0.03
0.03
0.04
0.11
0.08
Interest Cover
-5.25
-6.64
405.79
43.00
48.57
26.45
54.66
45.40
24.06
53.94

News Update:


  • Unichem Laboratories gets nod for Guanfacine Tablets
    4th Mar 2021, 16:08 PM

    The product will be commercialized from Unichem’s Ghaziabad Plant

    Read More
  • Unichem Laboratories gets approval for Apremilast Tablets
    19th Feb 2021, 11:20 AM

    Apremilast tablets are indicated for the treatment of adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy

    Read More
  • Unichem Laboratories gets approval for Zonisamide Capsules
    27th Jan 2021, 16:44 PM

    The product will be commercialized from Unichem’s Goa Plant

    Read More
  • Unichem Laboratories gets ANDA approval for Celecoxib Capsules
    13th Jan 2021, 12:54 PM

    The product will be commercialized from Unichem’s Goa Plant

    Read More
  • ICRA reaffirms Unichem Laboratories’ long-term rating
    8th Jan 2021, 15:58 PM

    The outlook on the long term rating has been revised to stable from negative

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.